Molecular pathogenesis of hepatocellular carcinoma
- PMID: 18069974
- DOI: 10.1111/j.1478-3231.2007.01637.x
Molecular pathogenesis of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer death worldwide. Hepatocarcinogenesis is a multistep process evolving from normal through chronic hepatitis/cirrhosis and dysplastic nodules to HCC. With advances in molecular methods, there is a growing understanding of the molecular mechanisms in hepatocarcinogenesis. Hepatocarcinogenesis is strongly linked to increases in allelic losses, chromosomal changes, gene mutations, epigenetic alterations and alterations in molecular cellular pathways. Some of these alterations are accompanied by a stepwise increase in the different pathological disease stages in hepatocarcinogenesis. Overall, a detailed understanding of the underlying molecular mechanisms involved in the progression of HCC is of fundamental importance to the development of effective prevention and treatment regimes for HCC.
Similar articles
-
Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations.Cancer Res. 2008 Jul 15;68(14):5988-96. doi: 10.1158/0008-5472.CAN-08-0905. Cancer Res. 2008. PMID: 18632655
-
[Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].Ai Zheng. 2005 Jun;24(6):757-68. Ai Zheng. 2005. PMID: 15946497 Review. Chinese.
-
Molecular and functional genetics of hepatocellular carcinoma.Front Biosci (Schol Ed). 2010 Jan 1;2(1):117-34. doi: 10.2741/s51. Front Biosci (Schol Ed). 2010. PMID: 20036934 Review.
-
Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.J Gastroenterol Hepatol. 2008 Jan;23(1):110-8. doi: 10.1111/j.1440-1746.2007.05250.x. J Gastroenterol Hepatol. 2008. PMID: 18171349
-
Early molecular and genetic determinants of primary liver malignancy.Surg Clin North Am. 2004 Apr;84(2):339-54. doi: 10.1016/S0039-6109(03)00226-3. Surg Clin North Am. 2004. PMID: 15062649 Review.
Cited by
-
Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging.PLoS One. 2013;8(3):e59869. doi: 10.1371/journal.pone.0059869. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555816 Free PMC article.
-
MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.World J Hepatol. 2015 Jun 18;7(11):1530-40. doi: 10.4254/wjh.v7.i11.1530. World J Hepatol. 2015. PMID: 26085912 Free PMC article. Review.
-
Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.J Proteome Res. 2010 Mar 5;9(3):1402-15. doi: 10.1021/pr900932y. J Proteome Res. 2010. PMID: 20000738 Free PMC article.
-
Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.Mol Cancer. 2012 Sep 11;11:64. doi: 10.1186/1476-4598-11-64. Mol Cancer. 2012. PMID: 22962849 Free PMC article.
-
Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest.Exp Ther Med. 2015 May;9(5):1709-1718. doi: 10.3892/etm.2015.2351. Epub 2015 Mar 13. Exp Ther Med. 2015. PMID: 26136881 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources